| Stem cell therapy: a potential for the perils of pancreatitis | Harleen CHELA,Bhupinder S. ROMANA,Markandeya MADABATTULA,Abdulmajeed A. ALBARRAK,Mohamad H. YOUSEF,Sami SAMIULLAH,Veysel TAHAN | 415–424 |
| Acute gastric injury after ingestion of substrate with hyperosmolar glucose and benzoate inversely related with small intestinal bacterial overgrowth | Yeon-Ji KIM,Chang-Nyol PAIK,Ji Min LEE,Dae Bum KIM,Jin Mo YANG | 425–432 |
| Effect of visceral fat tissue on superior mesenteric artery configuration: Is it superior to BMI? | Fatma Esra BAHADIR ÜLGER | 433–440 |
| Gastric and small intestinal traditional serrated adenomas: a detailed morphologic and immunohistochemical analysis | SABA KİREMİTCİ,Cevriye CANSIZ ERSÖZ,Berna SAVAŞ,Arzu ENSARİ | 441–450 |
| Antiplatelet agents’-ticagrelol and eptifibatide-safety in experimental colitis in mice | Stanko PETROVIC,Milijana VASILIJEVSKA,Slobodan OBRADOVIC,Dino TARABAR,Radoje DODER,Ivana MAJSTOROVIC,Marijana PETROVIC,Zvonko MAGIC,Bojana CIKOTA ALEKSIC,Nenad PERISIC,Irina BRCEREVIC,Nebojsa MANOJLOVIC,Nemanja RANCIC | 451–458 |
| Bone marrow mesenchymal stem cells differentiate into intestinal epithelioid cells through the ERK1/2 pathway | Ting JIANG,Meng-lin SHI,Geng XIA,Yi-na YANG,Jia-min XU,Yun-jie LEI,Ying-mei TANG,Jin-hui YANG | 459–465 |
| Symptomatic response to GERDOFF® in patients with gastro-esophageal reflux disease and poor response to alginates: an exploratory, post-market, open-label study | Valentina BOARINO,Ivana RAGUZZI,Margherita MAROCCHI,Alberto MERIGHI | 466–474 |
| Desmopressin acetate decreases blood loss in patients with massive hemorrhage undergoing gastrointestinal surgery | Li-Chun WANG,Ying-Fang HU,Lei CHEN,Rui XING,Xin-Feng LIN,Qiu-Ye KOU | 474–481 |
| The Turkish version of the childhood bladder and bowel dysfunction questionnaire (CBBDQ): Cross–cultural adaptation, reliability and construct validity | Gamze AYDIN,Marieke L. van Engelenburg - van LONKHUYZEN,Seda BAKTIR,EBRU KAYA MUTLU,Caner MUTLU,Rob A. de BIE | 482–488 |